# EDGAR Filing Document

**Accession Number:** 0001231457
**File Stem:** 0001937513-26-000005
**Filing Date:** 2026-2
**Character Count:** 8458
**Document Hash:** 8a1713c37aac965e3b01826f9348e0ae
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001937513-26-000005.hdr.sgml**: 20260217

**ACCESSION NUMBER**: 0001937513-26-000005

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260217

**DATE AS OF CHANGE**: 20260217

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GENELUX Corp
- **CENTRAL INDEX KEY:** 0001231457
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94094
- **FILM NUMBER:** 26644041

**BUSINESS ADDRESS:**
- **STREET 1:** 2625 TOWNSGATE ROAD, SUITE 230
- **CITY:** WESTLAKE VILLAGE
- **STATE:** CA
- **ZIP:** 91361
- **BUSINESS PHONE:** 805-267-9889

**MAIL ADDRESS:**
- **STREET 1:** 2625 TOWNSGATE ROAD, SUITE 230
- **CITY:** WESTLAKE VILLAGE
- **STATE:** CA
- **ZIP:** 91361

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GENELUX CORP
- **DATE OF NAME CHANGE:** 20030508
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Szalay Aladar
- **CENTRAL INDEX KEY:** 0001937513

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A

**MAIL ADDRESS:**
- **STREET 1:** 7704 N FORK RD.
- **CITY:** HIGHLAND
- **STATE:** CA
- **ZIP:** 92346

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**(Amendment No. 3)**

**Issuer:** GENELUX CORP

**Title of Class of Securities:** Common Stock, par value $0.001 per share

**CUSIP Number:** 36870H103

**Date of Event Which Requires Filing of this Statement:** 12/31/2025

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [ ] Rule 13d-1(c)

- [x] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>Aladar Szalay | Names of Reporting Persons<br>Aladar Szalay |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>X1 | Citizenship or Place of Organization<br>X1 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>1149821.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>1984465.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>1149821.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>1984465.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>3134286.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>3134286.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>8.2% | Percent of Class Represented by Amount in Row (9)<br>8.2% |
| 12. | Type of Reporting Person (See Instructions)<br>IN | Type of Reporting Person (See Instructions)<br>IN |

---

**Item 1(a). Name of Issuer:**
GENELUX CORP

**Item 1(b). Address of Issuer's Principal Executive Offices:**
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361.

**Item 2(a). Name of Person Filing:**
Aladar Szalay

**Item 2(b). Address of Principal Business Office:**
7704 North Fork Rd., Highland, CA 92346

**Item 2(c). Citizenship:**
United States

**Item 2(d). Title of Class of Securities:**
Common Stock, par value $0.001 per share

**Item 2(e). CUSIP Number:**
36870H103

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

See Row 9 of cover page.
Consists of (i) 599,821 shares of common stock held by The Szalay 2010 Retained Annuity Trust, (ii) 550,000 shares of common stock held by The Szalay 2010 Children's Trust, forwhich the reporting person has sole voting and dispositive power, (iii) 5,000 shares of common stock held by the reporting person's spouse and (iv) 1,979,465 held by Szalay Trust
Dated August 30th 2021, for which the reporting person has shared voting and dispositive power.

**(b) Percent of class:**

See Row 11 of cover page.
This percentage is calculated based on 38,051,771 shares of common stock outstanding as of October 30, 2025, as reported in Genelux Corporation's Form 10-Q, filed with the
Securities and Exchange Commission on November 5, 2025.

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

See Row 5 of cover page for the Reporting Person.
Consists of (i) 599,821 shares of common stock held by The Szalay 2010 Retained Annuity Trust and (ii) 550,000 shares of common stock held by The Szalay 2010 Children's Trust, for which the reporting person has sole voting and dispositive power.

**(ii) Shared power to vote or to direct the vote:**

See Row 6 of cover page for the Reporting Person.
Consists of 5,000 shares of common stock held by the reporting person's spouse and 1,979,465 held by Szalay Trust Dated August 30th 2021, for which the reporting person has shared voting and dispositive power.

**(iii) Sole power to dispose or to direct the disposition of:**

See Row 7 of cover page for the Reporting Person.
Consists of (i) 599,821 shares of common stock held by The Szalay 2010 Retained Annuity Trust and (ii) 550,000 shares of common stock held by The Szalay 2010 Children's Trust, for which the reporting person has sole voting and dispositive power.

**(iv) Shared power to dispose or to direct the disposition of:**

See Row 8 of cover page for the Reporting Person.
Consists of 5,000 shares of common stock held by the reporting person's spouse and 1,979,465 held by Szalay Trust Dated August 30th 2021, for which the reporting person has shared voting and dispositive power.

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Not Applicable

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

—

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Aladar Szalay**

**Date:** 02/17/2026

**By:** /s/ Aladar Szalay

**Name & Title:** Aladar Szalay